Cargando…

Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines

A role for second-generation antipsychotics (SGAs) in the treatment of panic disorders (PD) has been proposed, but the actual usefulness of SGAs in this disorder is unclear. According to the PRISMA guidelines, we undertook an updated systematic review of all of the studies that have examined, in ran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perna, Giampaolo, Alessandra, Alciati, Raffaele, Balletta, Elisa, Mingotto, Giuseppina, Diaferia, Paolo, Cavedini, Maria, Nobile, Daniela, Caldirola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849007/ https://www.ncbi.nlm.nih.gov/pubmed/27089322 http://dx.doi.org/10.3390/ijms17040551

Ejemplares similares

Experimental Drugs for Panic Disorder: An Updated Systematic Review
por: Caldirola, Daniela, et al.
Publicado: (2021)

The Co-Morbidity between Bipolar and Panic Disorder in Fibromyalgia Syndrome
por: Alciati, Alessandra, et al.
Publicado: (2020)

Management of Treatment-Resistant Panic Disorder
por: Perna, Giampaolo, et al.
Publicado: (2017)

Impact of respiratory protective devices on respiration: Implications for panic vulnerability during the COVID-19 pandemic.
por: Perna, Giampaolo, et al.
Publicado: (2020)

Is panic disorder a disorder of physical fitness? A heuristic proposal
por: Perna, Giampaolo, et al.
Publicado: (2018)

COVID-19 and panic disorder: clinical considerations for the most physical of mental disorders
por: Perna, Giampaolo, et al.
Publicado: (2020)

Expert opinion in panic disorder: The impact of COVID-19-related fears, protective devices, and lockdown on panic and agoraphobia
por: Caldirola, Daniela, et al.
Publicado: (2021)

Toward a personalized therapy for panic disorder: preliminary considerations from a work in progress
por: Caldirola, Daniela, et al.
Publicado: (2019)

C-reactive protein in a naturalistic sample of inpatients with major depressive disorder, bipolar disorder and obsessive-compulsive disorder
por: Caldirola, D., et al.
Publicado: (2021)

Are Anxiety Disorders Associated with Accelerated Aging? A Focus on Neuroprogression
por: Perna, Giampaolo, et al.
Publicado: (2016)

Human-Induced Pluripotent Stem Cell Technology: Toward the Future of Personalized Psychiatry
por: Alciati, Alessandra, et al.
Publicado: (2022)

Cardiorespiratory Assessments in Panic Disorder Facilitated by Wearable Devices: A Systematic Review and Brief Comparison of the Wearable Zephyr BioPatch with the Quark-b2 Stationary Testing System
por: Caldirola, Daniela, et al.
Publicado: (2023)

Anticonvulsant and antipsychotic medications in the pharmacotherapy of panic disorder: a structured review
por: Masdrakis, Vasilios G., et al.
Publicado: (2021)

Short-Term Psychiatric Rehabilitation in Major Depressive and Bipolar Disorders: Neuropsychological-Psychosocial Outcomes
por: Perna, Giampaolo, et al.
Publicado: (2017)

Personalized Psychiatry and Depression: The Role of Sociodemographic and Clinical Variables
por: Perna, Giampaolo, et al.
Publicado: (2020)

Commentary: Cognitive Behavioral Therapy vs. Eye Movement Desensitization and Reprocessing for Treating Panic Disorder: A Randomized Controlled Trial
por: Perna, Giampaolo, et al.
Publicado: (2018)

Pharmacotherapy of panic disorder
por: Pull, Charles B, et al.
Publicado: (2008)

Balance Rehabilitation with Peripheral Visual Stimulation in Patients with Panic Disorder and Agoraphobia: An Open-Pilot Intervention Study
por: Caldirola, Daniela, et al.
Publicado: (2023)

First-onset major depression during the COVID-19 pandemic: A predictive machine learning model
por: Caldirola, Daniela, et al.
Publicado: (2022)

Are anxiety disorders associated with accelerated ageing and cognitive decline? A multicenter italian study in middle aged and older patients and controls
por: Daccò, S., et al.
Publicado: (2021)

No Sex Differences in Self-Reported Childhood Maltreatment in Major Depressive and Bipolar Disorders: A Retrospective Study
por: Caldirola, Daniela, et al.
Publicado: (2022)

Genetic Testing for Antipsychotic Pharmacotherapy: Bench to Bedside
por: Shad, Mujeeb U.
Publicado: (2021)

Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition
por: Perna, Giampaolo, et al.
Publicado: (2011)

Blinded by PRISMA: Are Systematic Reviewers Focusing on PRISMA and Ignoring Other Guidelines?
por: Fleming, Padhraig S., et al.
Publicado: (2014)

Pharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018
por: Zugliani, Morena M., et al.
Publicado: (2019)

Clinical aspects of adherence to pharmacotherapy in Parkinson disease: A PRISMA-compliant systematic review
por: Straka, Igor, et al.
Publicado: (2018)

Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies
por: Kositsyn, Yuriy M., et al.
Publicado: (2023)

Drug pollution and pharmacotherapy in psychiatry: A “platypus” in the room
por: Lertxundi, Unax, et al.
Publicado: (2020)

Executive summary of the Clinical Guidelines of Pharmacotherapy for Neuropathic Pain: second edition by the Japanese Society of Pain Clinicians
por: Sumitani, Masahiko, et al.
Publicado: (2018)

PRISMA guideline compliance is imperative for systematic review appraisal
por: McKeown, Sandra
Publicado: (2020)

Effects of zinc sulfate on schizophrenia symptoms in patients undergoing atypical antipsychotic pharmacotherapy
por: Behrouzian, Forouzan, et al.
Publicado: (2022)

Defining ‘elderly’ in clinical practice guidelines for pharmacotherapy
por: Singh, Shamsher, et al.
Publicado: (2014)

Breaking the Fear Barrier: Aberrant Activity of Fear Networks as a Prognostic Biomarker in Patients with Panic Disorder Normalized by Pharmacotherapy
por: Yan, Haohao, et al.
Publicado: (2023)

Case-finding for disabilities with PRISMA-7 in emergency rooms: evolution in Sherbrooke, Québec
por: Raîche, Michel, et al.
Publicado: (2009)

A Novel Ensemble-Based Machine Learning Algorithm to Predict the Conversion From Mild Cognitive Impairment to Alzheimer's Disease Using Socio-Demographic Characteristics, Clinical Information, and Neuropsychological Measures
por: Grassi, Massimiliano, et al.
Publicado: (2019)

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
por: Page, Matthew J., et al.
Publicado: (2021)

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
por: Page, Matthew J., et al.
Publicado: (2021)

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
por: Page, Matthew J, et al.
Publicado: (2021)

JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
por: Ono, Katsushige, et al.
Publicado: (2022)

Comparative Treatment Patterns, Resource Utilization, and Costs in Stimulant-Treated Children with ADHD Who Require Subsequent Pharmacotherapy with Atypical Antipsychotics Versus Non-Antipsychotics
por: Sikirica, Vanja, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q9145rljfk8378a2j94n645rgn